Tech Center 4100 • Art Units: 1632 1647 4111
This examiner grants 24% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17082955 | SEPARATION MOIETIES AND METHODS OF USE THEREOF | Non-Final OA | Werewolf Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy